Pelagos Insurance

Pelagos Insurance Capital Ltd is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 2% premium over our quantitative fair value estimate of $24.14 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's lack of growth weakens our quantitative valuation. Stagnant revenue and earnings growth indicates a company's challenges in increasing market share and profitability. Reflecting the firm's growth is its EBIT 3-year growth of -53.7%, which lies in the bottom 10% globally. Earnings before interest and taxes has exhibited poor growth over the last three years. The future could be difficult for the firm, which contributes to our view that shares are overvalued.

Conversely, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 110.7%, a core component of valuation, sits in the top 30% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.